NEW YORK and BERLIN, Nov. 14, 2023 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health ...
A webcast of the company’s fireside chat will be available on atai’s website under Events on the Investors section of the atai website: https://ir.atai.life/news ...
The webcast for the fireside chat will be available on atai’s website under Events on the Investors section of the atai website: https://ir.atai.life/news-events ...
ATAI Life Sciences (NASDAQ:ATAI) just reported results for the fourth quarter of 2023. ATAI Life Sciences reported earnings per share of -12 cents. This was above the analyst estimate for EPS of -16 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results